The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
This significant milestone enhances our global regulatory standing
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
The transaction structured as share swap, is valued at ~Rs. 849 crore, with no cash outflow
The Board has also approved plans to invest approximately Rs. 500 crores including cost of land in developing a state-of-the-art, 400-bed super specialty hospital
This approval authorizes the company to export Ibuprofen to the Chinese markets
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Subscribe To Our Newsletter & Stay Updated
